This inventor holds 1 USPTO granted patent. Top assignee: Seagen Inc.. Active years: 2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022
Title: Courtney Beers: Innovator in Anti-TIGIT Antibodies
Introduction
Courtney Beers is a notable inventor based in Bothell, WA (US). He has made significant contributions to the field of immunology, particularly through his work on anti-TIGIT antibodies. His innovative approach has the potential to impact therapeutic strategies in cancer treatment.
Latest Patents
Courtney Beers holds 1 patent related to isolated antibodies that bind to human TIGIT (T-cell immunoreceptor with Ig and ITIM domains). This patent describes antibodies with a binding affinity (K) for human TIGIT of less than 5 nM. Additionally, the anti-TIGIT antibody is designed to block the binding of CD155 and/or CD112 to TIGIT. Some embodiments of the antibodies are afucosylated, enhancing their therapeutic potential.
Career Highlights
Courtney Beers is currently employed at Seagen Inc., a company known for its focus on developing innovative cancer therapies. His work at Seagen has positioned him as a key player in the advancement of antibody-based treatments.
Collaborations
Courtney collaborates with talented professionals such as Scott Peterson and Bianka Prinz, who contribute to the innovative environment at Seagen Inc. Their combined expertise fosters a culture of creativity and scientific advancement.
Conclusion
Courtney Beers is a pioneering inventor whose work on anti-TIGIT antibodies exemplifies the intersection of innovation and therapeutic development. His contributions are poised to make a significant impact in the field of immunology and cancer treatment.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile